The proposed regulatory model suggests that hypermethylation at five cytosine loci within the NKAPL promoter may obstruct NRF1 binding, either by diminishing its affinity [120] or through MBD protein binding, resulting in its down-expression in tumor samples. This evidence concerns the gene NKAPL and neoplasm.